FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

47663000: Clindamycin palmitate hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
79435011 Clindamycin palmitate hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
785146011 Clindamycin palmitate hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2478723014 Clindamycin palmitate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
801421000172116 chlorhydrate de palmitate de clindamycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clindamycin palmitate hydrochloride Is a Product containing clindamycin (medicinal product) false Inferred relationship Some
Clindamycin palmitate hydrochloride Is a Clindamycin (substance) false Inferred relationship Some
Clindamycin palmitate hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Clindamycin (substance) true Inferred relationship Some
Clindamycin palmitate hydrochloride Is a Pyrrolidine true Inferred relationship Some
Clindamycin palmitate hydrochloride Is a Antibacterial true Inferred relationship Some
Clindamycin palmitate hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Clindamycin palmitate hydroc 75 mg/ 5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clindamycin palmitate hydrochloride Inferred relationship Some
Clindamycin palmitate hydroc 75mg/5mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clindamycin palmitate hydrochloride Inferred relationship Some
Clindamycin 75mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Clindamycin palmitate hydrochloride Inferred relationship Some
Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Clindamycin palmitate hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start